Posted on 2/12/21
Caladrius Biosciences Announces $65 Million Registered Direct Offerings
BASKING RIDGE, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 2/12/21
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
When Pfizer (NYSE:PFE) included statistics in its recent earnings release showing its pipeline performance over the past five years, there was a not-so-subtle message. The blue-chip . . .
Posted on 2/12/21
Johnson & Johnson's Coronavirus Vaccine Data Isn't as Bad as It First Appears
In this video from Motley Fool Live, recorded on Feb. 1, Fool.com Contributors Brian Orelli and Keith Speights discuss the phase 3 clinical trial results for . . .
Posted on 2/12/21
Applied Therapeutics Prices Public Offering of 3M Shares of Common Stock
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated . . .
Posted on 2/11/21
DLA Piper Advises EQ Health Acquisition Corp. in its Upsized $220 Million IPO
DLA Piper represented EQ Health Acquisition Corp. in its recent upsized initial public offering of 21,999,960 units at a price of $10 per unit. Each unit . . .
Posted on 2/11/21
Columbia Care Announces C$25 Million Bought Private Placement Offering
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. . . .
Posted on 2/11/21
Signify Health Prices of IPO
DALLAS & NORWALK, Conn.--(BUSINESS WIRE)--Signify Health, Inc. a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, today announced the pricing of . . .
Posted on 2/11/21
VYNE Therapeutics Announces Reverse Stock Split
BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced that its Board of Directors has approved a reverse stock split . . .
Posted on 2/11/21
Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.(Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and . . .
Posted on 2/11/21
Acorda Therapeutics Sale of Manufacturing Operations to Catalent
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has completed the sale of its manufacturing operations in Chelsea, Massachusetts to Catalent. Under the . . .
Posted on 2/11/21
What Are Pfizer's Prospects in 2021 and Beyond?
Pfizer(NYSE:PFE) missed Wall Street's earnings estimate when the big drugmaker reported its fourth-quarter results recently. However, those results didn't account for the tremendous growth that the . . .
Posted on 2/11/21
Ortho Clinical Diagnostics: What You Need to Know
In this episode of Industry Focus: Wildcard, host Jason Moser and Motley Fool contributor Brian Feroldi take a closer look at Ortho Clinical Diagnostics' (NASDAQ:OCDX) debut . . .
Posted on 2/11/21
Bioasis Announces Shares for Debt Transaction
NEW HAVEN, Conn., Feb. 10, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology . . .
Posted on 2/11/21
Prestige Consumer Healthcare Prices $600 Million Senior Notes
TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. has priced an upsized offering . . .
Posted on 2/11/21
Applied Therapeutics Announces Offering of 3M Shares of Common Stock
NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates . . .
Posted on 2/11/21
Scopus BioPharma Announces Closing of Underwriters' Over-Allotment Option in Full
Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of the underwriters' over-allotment option in full, bringing total follow-on public offering proceeds to $10.35 million.Scopus is . . .
Posted on 2/10/21
Foothold Technology Acquires Relevant Health Homes
Today, Foothold Technology, a leading cloud-based behavioral health and human services EHR software provider backed by ASG, announced its acquisition of Relevant Health Homes,
Posted on 2/10/21
Catalent Launch of Private Offering of $475 Million of Senior Unsecured Notes
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and . . .
Posted on 2/10/21
2021's States with the Best & Worst Dental Health - WalletHub Study
With February being National Children’s Dental Health Month and the CDC reporting no COVID-19 transmissions in a clinical dental setting, the personal-finance website WalletHub today released . . .
Posted on 2/10/21
Prestige Consumer Healthcare Offers of $500 Million Senior Notes
TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) announced today that its wholly-owned subsidiary, Prestige Brands, Inc., intends to offer, subject . . .
Posted on 2/10/21
Can COVID Vaccine Latecomer Ocugen Beat Pfizer and Moderna?
Several days ago, Ocugen (NASDAQ:OCGN) was an early-stage biotech company focusing on gene therapy to cure eye diseases. And then everything changed. All of a sudden, . . .
Posted on 2/10/21
How Will Johnson & Johnson's COVID Vaccine Affect Its Stock?
Healthcare giant Johnson & Johnson(NYSE:JNJ) recently announced results from late-stage clinical study of the company's COVID-19 vaccine candidate. The news didn't cause a huge immediate move . . .
Posted on 2/10/21
Vislink Technologies Closes $50M Registered Direct Offering
HACKETTSTOWN, NJ, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (NASDAQ: VISL), the global technology leader in collection, delivery and management of high quality, live . . .
Posted on 2/10/21
Tonix Pharmaceuticals Holdings Corp. Closes $70M Common Stock Offering
CHATHAM, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced . . .
Posted on 2/10/21
Ortho Clinical Diagnostics Amends Credit Agreement
RARITAN, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today . . .
New York
